leadxpro specializes in structure-based drug discovery for membrane proteins. We combine membrane protein science from gene to biophysical methods and structural biology using cryo-EM and X-ray methods. So far, we have established over 105 drug targets accelerating drug discovery efforts worldwide.
Products, services, technology
We provide end-to-end drug discovery support: high-quality membrane proteins, biophysical characterization, structural biology for ligand interactions, advanced computational chemistry, and lead discovery from hit identification to lead optimization.
Cooperation possibilities
At leadxpro, we work hand-in-hand with our partners from gene to structure and through lead discovery. Every project is tailored to your goals, whether exploring a new target or advancing an established one in membrane protein drug discovery.
- http://www.leadxpro.com
- +41 79 770 97 24
- Send an email
- Michael Hennig, Prof. Dr.
Some insights
leadXpro improves human global health by reducing uncertainty in early drug discovery, enabling faster, evidence-driven development of new therapies that genuinely make a difference for patients worldwide.
leadXpro’s uncompromising scientific standards and collaborative culture, where multidisciplinary teams tackle complex membrane protein challenges with rigor, creativity, and a constant drive for excellence.
leadXpro’s team combines deep expertise in membrane proteins, incl. protein engineering, expression, biophysical assays, and structural biology via cryo-EM and X-ray crystallography, to tackle drug discovery challenges, while actively integrating emerging technologies to drive future innovation.
